28 October 2024
IXICO PLC
("IXICO" or the "Company")
Director/PDMR Share Dealings
Further to the announcements made on 8 October 2024 and 25 October 2024, and pursuant to the recent fundraising, the Company confirms that the following directors of the Company have subscribed for New Ordinary Shares at the Issue Price of 9.5 pence per Ordinary Share as follows:
| Director/PDMR Name | No. of New Ordinary Shares Subscribed | Resultant Shareholding post transaction | % of voting rights post transaction |
| Bram Goorden | 526,315 | 526,315 | 0.6% |
| Grant Nash | 105,263 | 505,263 | 0.5% |
| Dipti Amin | 105,263 | 105,263 | 0.1% |
| Katherine Rogers | 52,631 | 52,631 | 0.1% |
For further information please contact:
| IXICO plc | +44 (0) 20 3763 7499 |
| Bram Goorden, Chief Executive Officer Grant Nash, Chief Financial Officer |
|
|
|
|
| Cavendish Capital Markets Limited (Nominated adviser and sole broker) | +44 (0) 20 7220 0500 |
| Giles Balleny / Dan Hodkinson (Corporate Finance) | |
| Nigel Birks (Life Sciences Specialist Sales) | |
| Harriet Ward (Corporate Broking) | |
| Michael F Johnson / Tamar Cranford Smith (Sales) | |
About IXICO
IXICO is dedicated to delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Huntington's disease, Parkinson's disease and Alzheimer's disease. The Company's purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in neuroscience by supporting pharmaceutical companies across all phases of CNS clinical research. IXICO's goal is to be a leading advocate of artificial intelligence in medical image analysis.
IXICO has developed and deployed breakthrough data analytics, at scale, through its remote access technology platform, to improve the return on investment in drug development and reduce risk and uncertainty in clinical trials for the Company's pharmaceutical clients.
More information is available on www.IXICO.com and follow us on X (formerly Twitter) @IXICOnews
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
| a)
| Name
| Bram Goorden | |||
| 2
| Reason for the notification
| ||||
| a)
| Position/status
| Chief Executive Officer | |||
| b)
| Initial notification /Amendment
| Initial | |||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
| a)
| Name
| IXICO plc | |||
| b)
| LEI
| 2138005M1F59O6HWSA97 | |||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
| a)
| Description of the financial instrument, type of instrument | Ordinary shares in IXICO plc
| |||
|
|
| ||||
| Identification code | ISIN: GB00BFXR4C20 | ||||
|
|
| ||||
| b)
| Nature of the transaction
| Subscription for Ordinary shares | |||
| c)
| Price(s) and volume(s) |
|
|
|
|
|
|
| Price(s) | Volume(s) |
| |
|
|
| 9.5 pence | 526,315 |
| |
|
|
|
|
|
| |
| d)
| Aggregated information |
| |||
|
|
| ||||
| - Aggregated volume | | ||||
|
|
| ||||
| - Price | | ||||
|
|
| ||||
| e)
| Date of the transaction
| 28 October 2024 | |||
| f)
| Place of the transaction
| Off Market Transaction | |||
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
| a)
| Name
| Grant Nash | |||
| 2
| Reason for the notification
| ||||
| a)
| Position/status
| Chief Financial Officer | |||
| b)
| Initial notification /Amendment
| Initial | |||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
| a)
| Name
| IXICO plc | |||
| b)
| LEI
| 2138005M1F59O6HWSA97 | |||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
| a)
| Description of the financial instrument, type of instrument | Ordinary shares in IXICO plc
| |||
|
|
| ||||
| Identification code | ISIN: GB00BFXR4C20 | ||||
|
|
| ||||
| b)
| Nature of the transaction
| Subscription for Ordinary shares | |||
| c)
| Price(s) and volume(s) |
|
|
|
|
|
|
| Price(s) | Volume(s) |
| |
|
|
| 9.5 pence | 105,263 |
| |
|
|
|
|
|
| |
| d)
| Aggregated information |
| |||
|
|
| ||||
| - Aggregated volume | | ||||
|
|
| ||||
| - Price | | ||||
|
|
| ||||
| e)
| Date of the transaction
| 28 October 2024 | |||
| f)
| Place of the transaction
| Off Market Transaction | |||
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
| a)
| Name
| Dipti Amin | |||
| 2
| Reason for the notification
| ||||
| a)
| Position/status
| Non-Executive Director | |||
| b)
| Initial notification /Amendment
| Initial | |||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
| a)
| Name
| IXICO plc | |||
| b)
| LEI
| 2138005M1F59O6HWSA97 | |||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
| a)
| Description of the financial instrument, type of instrument | Ordinary shares in IXICO plc
| |||
|
|
| ||||
| Identification code | ISIN: GB00BFXR4C20 | ||||
|
|
| ||||
| b)
| Nature of the transaction
| Subscription for Ordinary shares | |||
| c)
| Price(s) and volume(s) |
|
|
|
|
|
|
| Price(s) | Volume(s) |
| |
|
|
| 9.5 pence | 105,263 |
| |
|
|
|
|
|
| |
| d)
| Aggregated information |
| |||
|
|
| ||||
| - Aggregated volume | | ||||
|
|
| ||||
| - Price | | ||||
|
|
| ||||
| e)
| Date of the transaction
| 28 October 2024 | |||
| f)
| Place of the transaction
| Off Market Transaction | |||
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
| a)
| Name
| Katherine Rogers | |||
| 2
| Reason for the notification
| ||||
| a)
| Position/status
| Non-Executive Director | |||
| b)
| Initial notification /Amendment
| Initial | |||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
| a)
| Name
| IXICO plc | |||
| b)
| LEI
| 2138005M1F59O6HWSA97 | |||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
| a)
| Description of the financial instrument, type of instrument | Ordinary shares in IXICO plc
| |||
|
|
| ||||
| Identification code | ISIN: GB00BFXR4C20 | ||||
|
|
| ||||
| b)
| Nature of the transaction
| Subscription for Ordinary shares | |||
| c)
| Price(s) and volume(s) |
|
|
|
|
|
|
| Price(s) | Volume(s) |
| |
|
|
| 9.5 pence | 52,631 |
| |
|
|
|
|
|
| |
| d)
| Aggregated information |
| |||
|
|
| ||||
| - Aggregated volume | | ||||
|
|
| ||||
| - Price | | ||||
|
|
| ||||
| e)
| Date of the transaction
| 28 October 2024 | |||
| f)
| Place of the transaction
| Off Market Transaction | |||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.